TOP 10 COMPANIES IN CANCER/TUMOR PROFILING MARKET
The Cancer/Tumor Profiling Market is poised
to witness substantial growth, projecting a robust Compound Annual Growth Rate
(CAGR) of 20.9% and an estimated market value exceeding $22.3 billion by 2030,
according to a recent report by Meticulous Research®. The evolution of
precision oncology, marked by the alignment of the right treatment with the
right patient at the right time, has significantly propelled cancer care,
contributing to a 27% decline in cancer mortality rates from 2001 to 2020.
Precision
Oncology Revolution: The success in reducing mortality rates is
primarily attributed to the adoption of targeted therapies, addressing
specific gene mutations driving cancer. This marks a departure from the
traditional one-size-fits-all approach of chemotherapy. Notably, targeted
treatments for advanced lung cancer have seen a substantial increase, with
over 15 FDA approvals since 2020.
Adoption of
Cancer/Tumor Profiling: Oncologists and
pathologists are increasingly turning to cancer/tumor profiling to enhance
their capabilities in identifying actionable biomarkers. This enables precise
matching of patients for clinical trials and precision therapies, marking a
paradigm shift in cancer treatment.
Market
Drivers: The growth of the cancer/tumor profiling
market is propelled by factors such as the increasing prevalence of cancer,
advancements in multi-omics tumor profiling and cancer research, rising
R&D investments by pharmaceutical and biotechnology companies for
biomarker development, government initiatives aimed at reducing cancer
mortality, and the utilization of biomarkers in tumor profiling.
Top 10
Companies in the Cancer/Tumor Profiling Market: Here are the leading companies driving innovation in the Cancer/Tumor
Profiling Market: https://meticulousblog.org/top-10-companies-in-cancer-tumor-profiling-market/
- Illumina, Inc.
(U.S.)
- Core Illumina
segment offers cancer/tumor profiling solutions.
- Global distribution
in North America, Europe, Latin America, Asia-Pacific, and the Middle
East & Africa.
- Thermo Fisher
Scientific Inc. (U.S.)
- Operates through
four segments: Life Sciences Solutions, Analytical Instruments,
Specialty Diagnostics, and Laboratory Products and Biopharma Services.
- Geographical
presence in North America, Europe, Asia-Pacific, Latin America, and the
Middle East & Africa.
- QIAGEN N.V.
(Netherlands)
- Provides sample and
assay technologies for molecular diagnostics and research.
- Global market
presence in more than 130 countries.
- F. Hoffmann-La
Roche Ltd (Switzerland)
- Engaged in Pharmaceuticals
and Diagnostics divisions.
- Global presence in
the U.S., Germany, Switzerland, Japan, China, India, and more.
- Agilent
Technologies, Inc. (U.S.)
- Offers
application-focused solutions to life sciences, diagnostics, and applied
chemical markets.
- Geographical
presence in North America, Europe, Asia-Pacific, Latin America, and the
Middle East & Africa.
- NanoString
Technologies, Inc. (U.S.)
- Focuses on
proteomics and genomics solutions.
- Global presence in
North America, Europe, and Asia-Pacific.
- HTG Molecular
Diagnostics, Inc. (U.S.)
- Specializes in
advanced drug discovery and transcriptome-wide profiling.
- Sales presence in
Austria, Belgium, France, Germany, Luxembourg, the Netherlands, the
U.K., and Switzerland.
- Agendia Inc.
(U.S.)
- Molecular
diagnostics company focused on breast cancer.
- Global delivery
through Agendia N.V. (Netherlands).
- Personalis, Inc.
(U.S.)
- Develops
comprehensive genomic tests with actionable insights.
- Serves diagnostics
companies, pharmaceutical companies, universities, and more.
- Exact Sciences
Corporation (U.S.)
- Provides advanced
cancer diagnostics solutions.
- Operates throughout
the U.S., Canada, Japan, and eight European countries.
Download Free Sample Report Here: https://www.meticulousresearch.com/download-sample-report/cp_id=5630
Upcoming
Industry Insights: For in-depth analysis, including recent
financial performance, key products, company strategies, and partnerships and
acquisitions, Meticulous Research®'s latest report on the Cancer/Tumor
Profiling Market – Global Opportunity Analysis and Industry Forecast
(2023-2030) provides comprehensive coverage.
For further
information, please contact:
Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Comments
Post a Comment